GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Accounts Payable

ProKidney (MEX:PROK) Accounts Payable : MXN56.03 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Accounts Payable?

ProKidney's Accounts Payable for the quarter that ended in Mar. 2024 was MXN56.03 Mil.

ProKidney's quarterly Accounts Payable increased from Sep. 2023 (MXN77.97 Mil) to Dec. 2023 (MXN86.54 Mil) but then declined from Dec. 2023 (MXN86.54 Mil) to Mar. 2024 (MXN56.03 Mil).

ProKidney's annual Accounts Payable increased from Dec. 2021 (MXN58.14 Mil) to Dec. 2022 (MXN59.35 Mil) and increased from Dec. 2022 (MXN59.35 Mil) to Dec. 2023 (MXN86.54 Mil).


ProKidney Accounts Payable Historical Data

The historical data trend for ProKidney's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Accounts Payable Chart

ProKidney Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accounts Payable
15.54 58.14 59.35 86.54

ProKidney Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.51 48.55 77.97 86.54 56.03

ProKidney Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


ProKidney Accounts Payable Related Terms

Thank you for viewing the detailed overview of ProKidney's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


ProKidney (MEX:PROK) Business Description

Traded in Other Exchanges
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.